All Products
B
M
R
S
U
W
Z
Find industry news, trends, and innovative products right here in our blog.
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
R
S
V
W
X
Learn about Entyvio’s FDA approval, its gut-selective action, and the recent subcutaneous formulation approval for ulcerative colitis and Crohn’s disease.
Discover how Entyvio works differently from traditional immunosuppressants. Learn about its gut-selective action, safety profile, and benefits for managing ulcerative colitis and...
Review the Entyvio dose schedule, from induction to maintenance, and learn how vedolizumab infusion timing supports long-term control of ulcerative colitis and...
Review key Entyvio prescribing information for practitioners, including dosing, administration, contraindications, and safety guidance for ulcerative colitis and Crohn’s disease.
Learn how Takeda Oncology, the manufacturer of Entyvio (vedolizumab), advances gut-selective treatments and leads innovation in inflammatory bowel disease care.
Learn about vedolizumab, the generic name for Entyvio—its structure, mechanism, biologic class, and biosimilar status in treating gut inflammation.
Learn what Entyvio is used for in ulcerative colitis, Crohn’s disease, and pouchitis—its dosing, clinical benefits, and gut-selective mechanism of action.
Understand Entyvio’s mechanism of action and how it helps manage ulcerative colitis and Crohn’s disease through selective gut-targeted immune modulation.
Learn about Entyvio side effects, from mild to rare risks like PML and liver injury, plus safety tips and monitoring guidance for...
Understand the relationship between Renflexis and Remicade. This guide explains biosimilarity, regulatory approval, and clinical interchangeability in autoimmune therapy.
Discover how Remicade works in treating Crohn's disease. Review its clinical effectiveness, potential side effects, and role in long-term management of inflammatory...
Explore the differences between Inflectra and Remicade, two infliximab-based treatments. Learn how biosimilars compare in terms of efficacy, safety, and cost for...